The p53 Colorectal Cancer Trial

Stopped The study was discontinued after the first pre-planned interim analysis due to insufficient response rates.

Conditions

• Colorectal Cancer Metastatic
• Colorectal Cancer Stage IV
• TP53 Gene Mutation

Interventions

• DRUG: Cyclophosphamide

Sponsor

Haukeland University Hospital